Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Clot Management Devices are used for the removal or dissolution of clots from blood vessels to restore proper blood circulation. GlobalData uses proprietary data and analytics to provide a comprehensive report on the clot management devices devices market, including market shares of different players within Switzerland. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the clot management devices market in Switzerland was Penumbra followed by Boston Scientific, Medtronic, Teleflex, Argon Medical Devices, AngioDynamics, Koninklijke Philips, Cook Medical, Terumo, Edwards Lifesciences, Merit Medical Systems, Inari Medical and LeMaitre Vascular.
The Clot Management Device is used in a routine intervention while performing percutaneous coronary interventions and to treat potentially life-threatening complications such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). This includes Inferior Vena Cava Filter (IVCF), Embolectomy Balloon Catheters, Thrombectomy Devices and Catheter-Directed thrombolysis (CDT) Catheters.
The value of the clot management devices devices market within Switzerland was expected to be over $20m in 2023.
For the latest complete market share analysis of clot management devices device market in Switzerland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.